Skip to main content

Kisspeptin Dosing and Reconstitution Explained

Last updated: July 2026

Reconstituting kisspeptin follows the exact same arithmetic as any other lyophilised peptide: you add a chosen volume of bacteriostatic water to the powder vial, that sets a milligrams-per-millilitre concentration, and your microgram dose divided by that concentration gives the volume — and therefore the U-100 syringe units — you draw. The only wrinkle unique to kisspeptin is that it comes in two forms with very different half-lives (kisspeptin-10 and kisspeptin-54), and its doses in the published human literature are measured in micrograms or micrograms-per-kilogram, not milligrams.

Have a kisspeptin vial and a target microgram dose? Convert powder + water into an exact mL and U-100 unit reading in seconds.

Open the peptide reconstitution calculator →

TL;DR — key takeaways

  • Kisspeptin is investigational. There is no FDA-approved kisspeptin product. Every dose figure on this page is drawn from published human research and is used only to demonstrate the reconstitution maths — not as a protocol to copy.
  • Two forms, two half-lives. Kisspeptin-10 clears in minutes; kisspeptin-54 lasts longer (roughly 28 minutes). That difference matters clinically, but it does not change how you reconstitute the vial.
  • Units follow concentration. The same 100 mcg dose can be 2 units or 4 units depending only on how much water you added. The peptide name is irrelevant to the arithmetic.
  • Doses are tiny. Because research doses sit in the tens-to-hundreds of micrograms, a typical draw is only a few units on a U-100 syringe, so a small measuring error is a large percentage error.

Kisspeptin-10 vs kisspeptin-54: what you are reconstituting

Kisspeptins are peptide fragments of the KISS1 gene product that act on the KISS1R (formerly GPR54) receptor to trigger hypothalamic gonadotropin-releasing hormone (GnRH) release, which in turn drives luteinising hormone (LH), follicle-stimulating hormone (FSH), and downstream testosterone or oestradiol. Two fragments dominate the human studies: the 10-amino-acid kisspeptin-10 and the 54-amino-acid kisspeptin-54. They bind the same receptor but differ in how long they persist in circulation, which is why researchers pick one over the other for bolus versus infusion work.

PropertyKisspeptin-10Kisspeptin-54
Amino acids1054
Approx. half-life~4 minutes~28 minutes
Typical research routeIV bolus / infusionSC bolus / IV infusion
Reported human doses~0.3–4 mcg/kgmicrograms to mcg/kg
ReconstitutionIdentical mathsIdentical maths

Notice the last row. The pharmacology differs, but the reconstitution step — powder plus water equals concentration — is byte-for-byte the same. What you do differently is the dose, which your prescriber or study protocol sets, never the arithmetic that converts it to units.

The reconstitution formula

Three numbers and two divisions cover every case. First, concentration: divide the vial's peptide mass by the water volume you add. Because kisspeptin doses are in micrograms, it is cleanest to express concentration in mcg/mL (1 mg = 1000 mcg). Second, volume: divide your dose by that concentration. Third, units: a U-100 syringe reads 100 units per 1 mL, so multiply the volume in mL by 100.

Written out: concentration (mcg/mL) = vial mcg ÷ water mL; volume (mL) = dose mcg ÷ concentration; units = volume mL × 100. Every worked example below is just those three lines with different numbers.

Worked examples

Example 1 — 5 mg vial, 2 mL water

A 5 mg kisspeptin-10 vial reconstituted with 2 mL BAC water: 5000 mcg ÷ 2 mL = 2500 mcg/mL. For a 100 mcg dose: 100 ÷ 2500 = 0.04 mL → 0.04 × 100 = 4 units.

Example 2 — 10 mg vial, 2 mL water

A 10 mg vial with 2 mL water: 10000 mcg ÷ 2 mL = 5000 mcg/mL. A 200 mcg dose: 200 ÷ 5000 = 0.04 mL → 4 units. Same units as Example 1, double the dose — because the vial is twice as concentrated.

Example 3 — a weight-based figure

Human studies often quote mcg/kg. Take the 1 mcg/kg bolus reported for kisspeptin-10: an 80 kg person is 80 mcg. From the 2500 mcg/mL vial in Example 1: 80 ÷ 2500 = 0.032 mL → 3.2 units. A tiny, hard-to-measure draw — which is exactly why concentration choice matters.

Example 4 — same vial, half the water

Reconstitute that same 5 mg vial with 1 mL instead of 2 mL: 5000 ÷ 1 = 5000 mcg/mL. Now a 100 mcg dose is 100 ÷ 5000 = 0.02 mL → 2 units. You changed nothing but the water and halved the units for an identical dose.

Example 5 — a more dilute vial for readable units

A 10 mg vial with 5 mL water: 10000 ÷ 5 = 2000 mcg/mL. A 250 mcg dose: 250 ÷ 2000 = 0.125 mL → 12.5 units. Diluting further pushes the draw to a larger, easier-to-read mark on the barrel.

Example 6 — keeping mg and mcg straight

Labels mix the units, so anchor on 1 mg = 1000 mcg. A "0.1 mg" dose is 100 mcg. From the 2000 mcg/mL vial in Example 5: 100 ÷ 2000 = 0.05 mL → 5 units. Confusing 0.1 mg with 1 mg would be a tenfold overdraw.

Dose-to-units reference chart

Common microgram doses shown as U-100 units at two typical reconstitutions. Always confirm against your own vial label and the volume of water you actually added.

DoseAt 2000 mcg/mLAt 5000 mcg/mL
50 mcg2.5 units1 unit
100 mcg5 units2 units
200 mcg10 units4 units
250 mcg12.5 units5 units
500 mcg25 units10 units

The diagram below shows why the draws are so short: at 5000 mcg/mL, even a 200 mcg dose is only 4 of the 100 marks on a 1 mL syringe.

020406080100 4 units 200 mcg ÷ 5000 mcg/mL = 0.04 mL = 4 units on a U-100 syringe U-100 syringe — 100 units = 1 mL

How this is calculated

Nothing here is a medical judgement. Every figure uses two fixed facts — a U-100 syringe holds 100 units per millilitre, and concentration is mass divided by volume — plus the milligram value printed on your vial and the water volume you chose. There is no kisspeptin-specific constant; the identical steps convert any vialled peptide, which is why the same reconstitution calculator handles BPC-157, GLP-1 medications, or kisspeptin. The maths cannot tell you whether a dose is appropriate, only how many units a given dose becomes. That clinical decision, and whether to use an investigational compound at all, belongs to a qualified prescriber.

Honest caveats on an investigational peptide

Kisspeptin has been studied in humans mainly to probe the reproductive axis — for example as a trigger in fertility treatment or as a diagnostic of GnRH-neuron function — not as an approved take-home therapy. The doses cited above come from controlled clinical settings with monitoring; they are not endorsements of self-administration. Purity, sterility, and actual peptide content of research-grade vials are unverified, so a vial labelled 5 mg may not contain 5 mg. Treat any figure here as arithmetic practice, and route real dosing decisions through a clinician and a reputable pharmacy.

Frequently asked questions

Does kisspeptin-54 need different reconstitution than kisspeptin-10?

No. The longer half-life of kisspeptin-54 changes how it behaves in the body, not how you mix it. Both use the same formula: vial mcg ÷ water mL = concentration, then dose ÷ concentration = volume.

Why are the syringe draws so small?

Because kisspeptin doses are measured in micrograms while a U-100 syringe spans 1000 mcg-equivalents of many peptides per mL at typical strengths. A 100 mcg dose from a 5000 mcg/mL vial is only 0.02 mL, or 2 units. Diluting with more water spreads the dose across more units for easier reading.

How do I convert a mcg/kg research dose to units?

Multiply the mcg/kg figure by body weight in kg to get the total mcg dose, then run the standard formula. A 1 mcg/kg dose for an 80 kg person is 80 mcg; from a 2500 mcg/mL vial that is 0.032 mL, about 3.2 units.

Is kisspeptin approved or safe to inject at home?

There is no FDA-approved kisspeptin product. It remains an investigational research peptide, and this page explains only the measurement maths, not a recommendation to use it. Discuss any reproductive-hormone intervention with a clinician.

Sources

  1. George JT, et al. Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men (J Clin Endocrinol Metab 2011)
  2. Dhillo WS, et al. Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males (J Clin Endocrinol Metab 2005)
  3. Narayanaswamy S, et al. Direct comparison of IV kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men (Clin Endocrinol 2016)
  4. Jayasena CN, et al. Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women (Clin Endocrinol 2016)
  5. Messager S, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54 (PNAS 2005)
  6. Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease (Hum Reprod Update 2014)
  7. Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans (eBioMedicine 2025)

This guide is for general educational purposes only and does not constitute medical advice. Always follow your prescriber’s specific instructions and consult a qualified clinician before changing any protocol.